Adult 0 5 0 5 O
men 6 9 6 9 B-gender

Female 0 6 10 16 B-gender
subjects 7 15 17 25 I-gender
who 16 19 26 29 O
are 20 23 30 33 O
pregnant 24 32 34 42 B-pregnancy

Has 0 3 43 46 O
ever 4 8 47 51 O
taken 9 14 52 57 O
the 15 18 58 61 O
any 19 22 62 65 O
anti 23 27 66 70 B-treatment
- 27 28 70 71 I-treatment
platelet 28 36 71 79 I-treatment
or 37 39 80 82 O
anti 40 44 83 87 B-treatment
- 44 45 87 88 I-treatment
coagulant 45 54 88 97 I-treatment
agents 55 61 98 104 I-treatment

Has 0 3 105 108 O
taken 4 9 109 114 O
NSAIDs 10 16 115 121 B-treatment
or 17 19 122 124 O
anti 20 24 125 129 B-treatment
- 24 25 129 130 I-treatment
secretory 25 34 130 139 I-treatment
agents 35 41 140 146 I-treatment
( 42 43 147 148 O
proton 43 49 148 154 B-treatment
pump 50 54 155 159 I-treatment
inhibitors 55 65 160 170 I-treatment
or 66 68 171 173 O
H2 69 71 174 176 B-treatment
receptor 72 80 177 185 I-treatment
antagonists 81 92 186 197 I-treatment
) 92 93 197 198 O
within 94 100 199 205 O
14 101 103 206 208 B-upper_bound
days 104 108 209 213 I-upper_bound
prior 109 114 214 219 I-upper_bound
to 115 117 220 222 O
study 118 123 223 228 O
drug 124 128 229 233 O
administration 129 143 234 248 O

Has 0 3 249 252 O
taken 4 9 253 258 O
any 10 13 259 262 O
prescription 14 26 263 275 B-treatment
medication 27 37 276 286 I-treatment
other 38 43 287 292 O
than 44 48 293 297 O
hormone 49 56 298 305 B-treatment
replacement 57 68 306 317 I-treatment
therapy 69 76 318 325 I-treatment
( 77 78 326 327 O
including 78 87 327 336 O
males 88 93 337 342 B-gender
taking 94 100 343 349 O
testosterone 101 113 350 362 O
as 114 116 363 365 O
a 117 118 366 367 O
hormone 119 126 368 375 O
replacement 127 138 376 387 O
to 139 141 388 390 O
treat 142 147 391 396 O
a 148 149 397 398 O
documented 150 160 399 409 O
low 161 164 410 413 O
testosterone 165 177 414 426 O
level 178 183 427 432 O
) 183 184 432 433 O
, 184 185 433 434 O
thyroid 186 193 435 442 B-treatment
replacement 194 205 443 454 I-treatment
hormones 206 214 455 463 I-treatment
, 214 215 463 464 O
anti 216 220 465 469 B-treatment
- 220 221 469 470 I-treatment
hyperlipidemic 221 235 470 484 I-treatment
agents 236 242 485 491 I-treatment
, 242 243 491 492 O
or 244 246 493 495 O
anti 247 251 496 500 B-treatment
- 251 252 500 501 I-treatment
hypertensive 252 264 501 513 I-treatment
medications 265 276 514 525 I-treatment
. 276 277 525 526 O
Individuals 278 289 527 538 O
taking 290 296 539 545 O
other 297 302 546 551 O
/ 302 303 551 552 O
additional 303 313 552 562 O
chronic 314 321 563 570 O
stable 322 328 571 577 O
medications 329 340 578 589 O
can 341 344 590 593 O
be 345 347 594 596 O
considered 348 358 597 607 O
on 359 361 608 610 O
a 362 363 611 612 O
case 364 368 613 617 O
- 368 369 617 618 O
by 369 371 618 620 O
- 371 372 620 621 O
case 372 376 621 625 O
basis 377 382 626 631 O
for 383 386 632 635 O
inclusion 387 396 636 645 O
in 397 399 646 648 O
the 400 403 649 652 O
study 404 409 653 658 O
if 410 412 659 661 O
agreed 413 419 662 668 O
upon 420 424 669 673 O
by 425 427 674 676 O
judgment 428 436 677 685 O
of 437 439 686 688 O
the 440 443 689 692 O
investigators 444 457 693 706 O

History 0 7 707 714 O
of 8 10 715 717 O
cancer 11 17 718 724 B-cancer
within 18 24 725 731 O
the 25 28 732 735 O
last 29 33 736 740 B-upper_bound
5 34 35 741 742 I-upper_bound
years 36 41 743 748 I-upper_bound

History 0 7 749 756 O
of 8 10 757 759 O
significant 11 22 760 771 O
cardiovascular 23 37 772 786 B-chronic_disease
disease 38 45 787 794 I-chronic_disease
( 46 47 795 796 O
including 47 56 796 805 O
stroke 57 63 806 812 B-chronic_disease
or 64 66 813 815 O
TIA 67 70 816 819 O
) 70 71 819 820 O
, 71 72 820 821 O
renal 73 78 822 827 O
, 78 79 827 828 O
hepatic 80 87 829 836 O
, 87 88 836 837 O
respiratory 89 100 838 849 O

Used 0 4 850 854 O
dietary 5 12 855 862 B-treatment
or 13 15 863 865 I-treatment
herbal 16 22 866 872 I-treatment
supplements 23 34 873 884 I-treatment
containing 35 45 885 895 O
salicylates 46 57 896 907 B-treatment
, 57 58 907 908 O
Vitamin 59 66 909 916 B-treatment
E 67 68 917 918 I-treatment
, 68 69 918 919 O
fish 70 74 920 924 B-treatment
oil 75 78 925 928 I-treatment
, 78 79 928 929 O
or 80 82 930 932 O
any 83 86 933 936 O
other 87 92 937 942 O
herbal 93 99 943 949 O
supplements 100 111 950 961 O
, 111 112 961 962 O
within 113 119 963 969 O
14 120 122 970 972 B-upper_bound
days 123 127 973 977 I-upper_bound
of 128 130 978 980 O
study 131 136 981 986 O
drug 137 141 987 991 O
administration 142 156 992 1006 O

Volunteers 0 10 1007 1017 O
with 11 15 1018 1022 O
adequately 16 26 1023 1033 O
controlled 27 37 1034 1044 O
hypertension 38 50 1045 1057 B-chronic_disease
and 51 54 1058 1061 O
hyperlipidemia 55 69 1062 1076 B-chronic_disease

coagulation 0 11 1077 1088 B-chronic_disease
, 11 12 1088 1089 O
bleeding 13 21 1090 1098 B-chronic_disease
or 22 24 1099 1101 O
blood 25 30 1102 1107 B-chronic_disease
disorders 31 40 1108 1117 I-chronic_disease

cutaneous 0 9 1118 1127 B-cancer
basal 10 15 1128 1133 I-cancer
cell 16 20 1134 1138 I-cancer
or 21 23 1139 1141 O
squamous 24 32 1142 1150 B-cancer
cell 33 37 1151 1155 I-cancer
cancer 38 44 1156 1162 I-cancer
resolved 45 53 1163 1171 O
by 54 56 1172 1174 O
excision 57 65 1175 1183 B-treatment
, 65 66 1183 1184 O
or 67 69 1185 1187 O
carcinoma 70 79 1188 1197 B-cancer
in 80 82 1198 1200 I-cancer
situ 83 87 1201 1205 I-cancer
of 88 90 1206 1208 I-cancer
the 91 94 1209 1212 I-cancer
cervix 95 101 1213 1219 I-cancer
adequately 102 112 1220 1230 O
treated 113 120 1231 1238 O

documented 0 10 1239 1249 O
history 11 18 1250 1257 O
of 19 21 1258 1260 O
any 22 25 1261 1264 O
gastrointestinal 26 42 1265 1281 B-chronic_disease
disorders 43 52 1282 1291 I-chronic_disease
, 52 53 1291 1292 O
including 54 63 1293 1302 O
bleeding 64 72 1303 1311 B-chronic_disease
ulcers 73 79 1312 1318 I-chronic_disease

greater 0 7 1319 1326 O
than 8 12 1327 1331 O
18 13 15 1332 1334 B-lower_bound
years 16 21 1335 1340 I-lower_bound
of 22 24 1341 1343 O
age 25 28 1344 1347 B-age

history 0 7 1348 1355 O
of 8 10 1356 1358 O
drug 11 15 1359 1363 O
or 16 18 1364 1366 O
alcohol 19 26 1367 1374 O
abuse 27 32 1375 1380 O
within 33 39 1381 1387 O
the 40 43 1388 1391 O
last 44 48 1392 1396 B-upper_bound
6 49 50 1397 1398 I-upper_bound
months 51 57 1399 1405 I-upper_bound

immune 0 6 1406 1412 B-chronic_disease
, 6 7 1412 1413 O
endocrine 8 17 1414 1423 B-chronic_disease
, 17 18 1423 1424 O
hematopoietic 19 32 1425 1438 B-chronic_disease
disorder 33 41 1439 1447 I-chronic_disease
or 42 44 1448 1450 O
neurological 45 57 1451 1463 B-chronic_disease
disorders 58 67 1464 1473 I-chronic_disease

infections 0 10 1474 1484 O
which 11 16 1485 1490 O
longer 17 23 1491 1497 O
> 24 25 1498 1499 O
6 26 27 1500 1501 B-lower_bound
months 28 34 1502 1508 I-lower_bound
prior 35 40 1509 1514 I-lower_bound
to 41 43 1515 1517 O
screening 44 53 1518 1527 O

received 0 8 1528 1536 O
an 9 11 1537 1539 O
investigational 12 27 1540 1555 B-treatment
drug 28 32 1556 1560 I-treatment
or 33 35 1561 1563 O
used 36 40 1564 1568 O
an 41 43 1569 1571 O
experimental 44 56 1572 1584 O
medical 57 64 1585 1592 O
device 65 71 1593 1599 O
within 72 78 1600 1606 O
30 79 81 1607 1609 B-upper_bound
days 82 86 1610 1614 I-upper_bound
prior 87 92 1615 1620 I-upper_bound
to 93 95 1621 1623 O
screening 96 105 1624 1633 O
, 105 106 1633 1634 O
or 107 109 1635 1637 O
who 110 113 1638 1641 O
gave 114 118 1642 1646 O
a 119 120 1647 1648 O
blood 121 126 1649 1654 O
donation 127 135 1655 1663 O
of 136 138 1664 1666 O
≥ 139 140 1667 1668 O
one 141 144 1669 1672 B-lower_bound
pint 145 149 1673 1677 O
within 150 156 1678 1684 O
8 157 158 1685 1686 B-upper_bound
weeks 159 164 1687 1692 I-upper_bound
prior 165 170 1693 1698 I-upper_bound
to 171 173 1699 1701 O
screening 174 183 1702 1711 O

sensitive 0 9 1712 1721 O
or 10 12 1722 1724 O
allergic 13 21 1725 1733 O
to 22 24 1734 1736 O
aspirin 25 32 1737 1744 B-allergy_name
or 33 35 1745 1747 O
other 36 41 1748 1753 O
NSAIDs 42 48 1754 1760 B-allergy_name

sensitive 0 9 1761 1770 O
or 10 12 1771 1773 O
allergic 13 21 1774 1782 O
to 22 24 1783 1785 O
celecoxib 25 34 1786 1795 B-allergy_name
( 35 36 1796 1797 I-allergy_name
Celebrex 36 44 1797 1805 I-allergy_name
) 44 45 1805 1806 I-allergy_name
or 46 48 1807 1809 O
naproxen 49 57 1810 1818 B-allergy_name
( 58 59 1819 1820 I-allergy_name
Naprosyn 59 67 1820 1828 I-allergy_name
) 67 68 1828 1829 I-allergy_name
or 69 71 1830 1832 O
their 72 77 1833 1838 O
components 78 88 1839 1849 O

total 0 5 1850 1855 B-clinical_variable
cholesterol 6 17 1856 1867 I-clinical_variable
of 18 20 1868 1870 O
≤270 21 25 1871 1875 O
mg 26 28 1876 1878 I-upper_bound
/ 28 29 1878 1879 I-upper_bound
dL 29 31 1879 1881 I-upper_bound

women 0 5 1882 1887 B-gender

